The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEkf Diagnostics Share News (EKF)

Share Price Information for Ekf Diagnostics (EKF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 29.90
Bid: 29.10
Ask: 30.70
Change: 0.10 (0.34%)
Spread: 1.60 (5.498%)
Open: 29.80
High: 0.00
Low: 0.00
Prev. Close: 29.80
EKF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Concepta Unveils Genomic Covid-19 Test And Plans Name Change

Wed, 02nd Dec 2020 09:55

(Alliance News) - Concepta PLC on Wednesday said it has launched a Covid-19 genomic testing kit, and the myLotus pregnancy test maker also outlined plans for a name change.

Shares in Concepta jumped 32% to 2.12 pence each in London on Wednesday morning.

The healthcare company and fertility tracking firm launched a DNA testing service under the MyHealthChecked brand, in the wake of Concepta's acquisition of Genome Store Ltd, announced in November.

Concepta parted with an initial GBP280,000 to buy the home-use genetic testing company, plus a deferred consideration of up to GBP240,000.

The company said the test will be a "COVID-19 lab-based PCR test".

"The MyHealthChecked Covid-19 testing service will use the Clarigene SARS-CoV-2 test supplied by Yourgene Health PLC and the PrimeStore MTM sample collection device supplied by EKF Diagnostic Holdings PLC," Concepta added.

"The MyHealthChecked testing service allows samples to be quickly and conveniently taken at home using simple nasal collection swabs which are then sent via free postage for processing using established laboratory-based DNA and RNA detection methods."

Looking ahead, Concepta said it plans to launch a "number of DNA tests", in fields such as male and female wellness and food intolerance.

"Our priority is to look beyond the pandemic with a range of affordable, meaningful at-home test kits, but it would be remiss of us - now with the expertise and operational channel in-house - not to make this kit available to the public," Concepta Chief Executive Officer Penny McCormick said.

The company added that the "requirement for at home testing kits is expected to continue", despite promising news on the vaccine front.

The UK government on Wednesday said it has authorised Pfizer Inc and BioNTech SE's Covid-19 vaccine, becoming the first country in the world to give the jab the green light.

In changes that will take effect in "due course" Concepta said its name will change to MyHealthChecked PLC.

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
2 Nov 2018 09:25

EKF Diagnostics Spin-Off Renalytix AI To Raise GBP22 Million In IPO (ALLIPO)

LONDON (Alliance News) - EKF Diagnostics Holdings PLC's spin-off Renalytix AI PLC confirmed Friday it expects to raise GBP22.3 million in its initial public offering.The Cardiff-based a

Read more
23 Oct 2018 14:45

Renalytix AI Will Submit Two Kidney Disease Products For US Approval

LONDON (Alliance News) - Renalytix AI PLC, a spin-out of EKF Diagnostics Holdings PLC, said Tuesday it intends to submit two artificial intelligence products for review by the US Food & Drug a

Read more
11 Oct 2018 16:55

EKF Diagnostics Spin-Out Raises GBP21 Million Through Share Issue (ALLISS)

LONDON (Alliance News) - Medical diagnostics company EKF Diagnostics Holdings PLC on Thursday said its spin-out company Renalytix AI PLC has raised a minimum of GBP21 million through equity AI to

Read more
19 Sep 2018 10:25

EKF Diagnostics Interim Profit Grows As Costs Fall Despite Revenue Dip

LONDON (Alliance News) - Medical devices maker EKF Diagnostics Holdings PLC said Wednesday its interim profit expanded as administrative costs fell, despite revenue dipping.For the six 21%

Read more
31 Aug 2018 14:21

EKF Diagnostics Looks To Investors For Possible Renalytix Listing (ALLIPO)

LONDON (Alliance News) - EKF Diagnostics Holdings PLC said Friday that it is looking to undertake further market soundings with investors for the potential listing on AIM of its division Renalytix

Read more
15 Aug 2018 15:25

Gabelli Value Plus Appoints Christopher Mills Non Executive Director

LONDON (Alliance News) - Gabelli Value Plus Trust PLC said Wednesday that it appointed Christopher Mills as non-executive director with immediate effect.Mills founded Harwood Capital in He

Read more
24 Jul 2018 18:14

Oryx Net Asset Value Rises In Full-Year On Portfolio Performance

LONDON (Alliance News) - Oryx International Growth Fund Ltd said Tuesday it will not pay a dividend for the year despite an increase in net asset value per share in the 12 months ended NAV per 10%

Read more
19 Jul 2018 12:26

EKF Diagnostics Signs Manufacturing Partnership With Oragenics

LONDON (Alliance News) - EKF Diagnostics Holdings PLC said Thursday it has signed an exclusive agreement with US pharmaceutical company Oragenics Inc to manufacture Oragenics lantibiotic bulk drug

Read more
31 May 2018 11:30

EKF Subsidiary Teams With Mount Sinai To Fight Kidney Disease

LONDON (Alliance News) - EKF Diagnostics Holdings PLC on Thursday said its subsidiary Renalytix AI PLC has secured an exclusive license and collaboration contract with the Icahn School of Medicine

Read more
14 Mar 2018 11:57

EKF Diagnostics Swings To 2017 Profit After Cost Reductions

LONDON (Alliance News) - EKF Diagnostics Holdings PLC on Wednesday reported "significantly" improved annual revenues, earnings, and cash as a result of its cost firm

Read more
9 Jan 2017 08:13

EKF Diagnostics flags budget-beating year

(ShareCast News) - Point-of-care business EKF Diagnostics Holdings announced on Monday that trading in the final quarter of the year ended 31 December was "materially better than budget", and that the overall performance for the year will exceed revised market forecasts, which themselves were recent

Read more
7 Nov 2016 12:07

EKF Diagnostics sees FY revenues, earnings ahead of market views

(ShareCast News) - AIM-listed point-of-care business EKF Diagnostics said on Monday that revenues and adjusted earnings for the year to the end of December are likely to be ahead of current market forecasts. EKF said early trading in the fourth quarter has again been "materially higher" than budg

Read more
12 Sep 2016 10:41

EKF Diagnostics boosts earnings in first half

(ShareCast News) - Point-of-care business EKF Diagnostics Holdings announced its unaudited interim results for the six months to 30 June on Monday, ahead of market expectations. The AIM-traded firm said it has an installed base of over 90,000 analysers globally and manufactures over 56 million tests

Read more
21 Jul 2016 10:33

DIRECTOR DEALINGS: EKF Diagnostics Chairman Ups Interest

Read more
18 Jul 2016 15:26

DIRECTOR DEALINGS: EKF Diagnostics Chairman Ups Interest

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.